In vitro adjuncts to the Pap smear

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 4, 2002, Pages 685-699

  Felix, Juan C ^a   Amezcua, Charles ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

CYTOLOGICAL TECHNIQUES; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036929564     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(02)00044-X     Document Type: Review

References (75)

1. Widra EA, Dookhan D, Jordan A, McCue P, Bibbo M, Dunton CJ. Evaluation of the atypical cytologic smear: Validity of the 1991 Bethesda System. J Reprod Med 1994;39:682-4.
2. Benedet JL, Anderson GH. Cervical intraepithelial neoplasia in British Columbia: A comprehensive program for detection, diagnosis, and treatment. Gynecol Oncol 1981;12(2 Pt 2):S280-91.
3. Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer 1974;34:2018-27.
4. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1987;8544:1247-9.
5. Macgregor JE, Moss S, Parkin DM, Day NE. Cervical cancer screening in North-East Scotland. IARC Sci Publ 1986;76:25-36.
6. New Papanicolaou test suggested for Air Force dependents. US Med 1978;8-15.
7. Bogdanich W. Lax laboratories: The Pap test misses much cervical cancer through labs' errors. Wall Street Journal November 11, 1987:1.
8. Meisels A. Cytologic diagnosis of human papillomavirus: Influence of age and pregnancy stage. Acta Cytol 1992;36:480-2.
9. Giles JA, Hudson E, Crow J, Williams D, Walker P. Colposcopic assessment of the accuracy of cervical cytology screening. BMJ 1988;296:1099-102.
10. Joseph MG, Cragg F, Wright VC, Kontozoglou TE, Downing P, Marks FR. Cyto-histological correlates in a colposcopic clinic: A 1-year prospective study. Diagn Cytopathol 1991;7:477-81.
11. Kristensen GB, Skyggebjerg KD, Holund B, Holm K, Hansen MK. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. Acta Cytol 1991;35:47-50.
12. MacCormac L, Lew W, King G, Allen PW. Gynaecological cytology screening in South Australia: A 23-year experience. Med J Aust 1988;149:530-6.
13. Mitchell H, Medley G, Giles G. Cervical cancers diagnosed after negative results on cervical cytology: Perspective in the 1980s. BMJ 1990;300:1622-6.
14. Plott AE, Martin FJ, Cheek SW, Yobs AR, Wood RJ. Measuring screening skills in gynecologic cytology: Results of voluntary self-assessment. Acta Cytol 1987;31:911-23.
15. Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B. The validation of cervical cytology: Sensitivity, specificity and predictive values. Acta Cytol 1991;35:8-14.
16. van der Graaf Y, Vooijs GP, Gaillard HL, Go DM. Screening errors in cervical cytologic screening. Acta Cytol 1987;31:434-8.
17. Yobs AR, Plott AE, Hicklin MD, Coleman SA, Johnston WW, Ashton PR, et al. Retrospective evaluation of gynecologic cytodiagnosis. II. Interlaboratory reproducibility as shown in rescreening large consecutive samples of reported cases. Acta Cytol 1987;31:900-10.
18. Hutchinson ML, Cassin CM, Ball III HG. The efficacy of an automated preparation device for cervical cytology. Am J Clin Pathol 1991;96:300-5.
19. Agency for Healthcare Policy and Research. Evidence Report/Technology Assessment No. 5: Evaluation of Cervical Cytology. Washington, DC: Agency for Healthcare Policy and Research Report No. 99-E010; 1999.
20. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy [see comments]. Am J Epidemiol 1995;141:680-9.
21. Hutchinson ML, Agarwal P, Denault T, Berger B, Cibas ES. A new look at cervical cytology: ThinPrep multicenter trial results. Acta Cytol 1992;36:499-504.
22. Felix JC, Lonky NM, Tamura K, Yu K-J, Naidu Y, Lai C-R, et al. Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with a false-negative Papanicolaou smear. Am J Obstet Gynecol 2002;186:1308-14.
23. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology for cervical carcinoma screening: Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma [see comments]. Cancer 1999;87:48-55.
24. Bishop JW, Bigner SH, Colgan TJ, Husain M, Howell LP, McIntosh KM, et al. Multicenter masked evaluation of AutoCyte Prep thin layers with matched conventional smears, including initial biopsy results. Acta Cytol 1998;42:189-97.
25. Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 1998;42:209-13.
26. Hutchinson ML, Isenstein LM, Goodman A, Hurley AA, Douglass KL, Mui KK, et al. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep processor. Am J Clin Pathol 1994;101:215-9.
27. Khalbuss WE, Rudomina D, Kauff ND, Chuang L, Melamed MR. SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: Data on 791 cases. Cancer 2000;90:135-42.
28. Aponte-Cipriani SL, Teplitz C, Rorat E, Savino A, Jacobs AJ. Cervical smears prepared by an automated device versus the conventional method: A comparative analysis. Acta Cytol 1995;39:623-30.
29. Awen C, Hathway S, Eddy W, Voskuil R, Janes C. Efficacy of ThinPrep preparation of cervical smears: A 1000-case, investigator-sponsored study. Diagn Cytopathol 1994;11:33-6.
30. Bur M, Knowles K, Pekow P, Corral O, Donovan J. Comparison of ThinPrep preparations with conventional cervicovaginal smears: Practical considerations. Acta Cytol 1995;39:631-42.
31. Ferenczy A, Robitaille J, Franco E, Arseneau J, Richart RM, Wright TC. Conventional cervical cytologic smears vs ThinPrep smears: A paired comparison study on cervical cytology. Acta Cytol 1996;40:1136-42.
32. Geyer JW, Hancock F, Carrico C, Kirkpatrick M. Preliminary evaluation of Cyto-Rich: An improved automated cytology preparation. Diagn Cytopathol 1993;9:417-22.
33. Laverty CR, Thurloe JK, Redman NL, Famsworth A. An Australian trial of ThinPrep: A new cytopreparatory technique. Cytopathology 1995;6:140-8.
34. McGoogan E, Reith A. Would monolayers provide more representative samples and improved preparations for cervical screening? Overview and evaluation of systems available. Acta Cytol 1996;40:107-19.
35. Sprenger E, Schwarzmarm P, Kirkpatrick M, Fox W, Heinzerling RH, Geyer JW, et al. The false negative rate in cervical cytology: Comparison of monolayers to conventional smears. Acta Cytol 1996;40:81-9.
36. Wilbur DC, Cibas ES, Merritt S, James LP, Berger BM, Bonfiglio TA. ThinPrep processor: Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens. Am J Clin Pathol 1994;101:209-14.
37. Wilbur DC, Dubeshter B, Angel C, Atkison KM. Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intraepithelial lesions and carcinomas. Diagn Cytopathol 1996;14:201-11.
38. Takahashi M, Naito M. Application of the CytoRich monolayer preparation system for cervical cytology: A prelude to automated primary screening. Acta Cytol 1997;41:1785-9.
39. Corkill ME, Knapp D, Hutchinson ML. Improved accuracy for cervical cytology with the ThinPrep method and the endocervical brush-spatula collection procedure. Journal of the Lower Female Genital Tract 1988;167:466-9.
40. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology for cervical carcinoma screening: Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999;87:48-55.
41. Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhom SL. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997;90:278-84.
42. Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CR. Evaluation of the Thinprep Pap test as an adjunct to the conventional Pap smear. Med J Aust 1997;167:466-9.
43. Shield PW, Nolan GR, Phillips GE, Cummings MC. Improving cervical cytology screening in a remote, high risk population. Med J Aust 1999;170:255-8.
44. Wang TY, Chen HS, Yang YC, Tsou MC. Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology. J Formos Med Assoc 1999;98:500-5.
45. Kunz J, Rondez R, Yoshizaki C, Fivian M, Held G, Lind B. Comparison of conventional Pap smears with thin layer specimen (liquid-based Pap test) and correlation with cytopathological findings with HPV status using the hybrid capture system. Schweiz Rundsch Med Prax 1998;87:1434-40.
46. Minge L, Fleming M, VanGeem T, Bishop JW. AutoCyte Prep system vs. conventional cervical cytology: Comparison based on 2,156 cases. J Reprod Med 2000;45:179-84.
47. Vassilakos P, Cossali D, Albe X, Alonso L, Hohener R, Puget E. Efficacy of monolayer preparations for cervical cytology: Emphasis on suboptimal specimens. Acta Cytol 1996;40:496-500.
48. Wilbur DC, Facik MS, Rutkowski MA, Mulford DK, Atkison KM. Clinical trials of the CytoRich specimen-preparation device for cervical cytology: Preliminary results. Acta Cytol 1997;41:24-9.
49. Carpenter AB, Davey DD. ThinPrep Pap test: Performance and biopsy follow-up in a university hospital. Cancer 1999;87:105-12.
50. Diaz-Rosario LA, Kabawat SE. Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med 1999;123:817-21.
51. Dupree WB, Suprun HZ, Beckwith DG, Shane JJ, Lucente V. The promise and risk of a new technology: The Lehigh Valley Hospital's experience with liquid-based cervical cytology. Cancer 1998;84:202-7.
52. Guidos BJ, Selvaggi SM. Use of the Thin Prep Pap test in clinical practice. Diagn Cytopathol 1999;20:70-3.
53. Papillo JL, Zarka MA, St John TL. Evaluation of the ThinPrep Pap test in clinical practice: A seven-month, 16,314-case experience in Northern Vermont. Acta Cytol 1998;42:203-8.
54. Weintraub J. The coming revolution in cervical cytology: A pathologist's guide for the clinician. (French) Reference du Gynecologic et Obstetrics 1997;5:2-6.
55. Weintraub J, Morabia A. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn Cytopathol 2000;22:52-9.
56. Tench W. Preliminary assessment of the AutoCyte Prep: Direct-to-vial performance. J Reprod Med 2000;45:912-6.
57. Vassilakos P, Griffin S, Megevand E, Campana A. CytoRich liquid-based cervical cytologic test: Screening results in a routine cytopathology service. Acta Cytol 1998;42:198-202.
58. Vassilakos P, Saurel J, Rondez R. Direct-to-vial use of the AutoCyte Prep liquid-based preparation for cervical-vaginal specimens in three European laboratories. Acta Cytol 1999;43:65-8.
59. Vassilakos P, Schwartz D, de Marval F, Yousfi L, Broquet G, Mathez-Loic F, et al. Biopsy-based comparison of liquid-based, thin-layer preparations to conventional Pap smears. J Reprod Med 2000;45:11-6.
60. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F. ThinPrep Pap test accuracy for glandular disease. Acta Cytol 1999;43:81-5.
61. Guidos BJ, Selvaggi SM. Use of the Thin Prep test in clinical practice. Diagn Cytopathol 1999;20:70-3.
62. Duggan MA. Papnet-assisted, primary screening of cervico-vaginal smears. Eur J Gynaecol Oncol 2000;21:35-42.
63. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Dax TD. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap system: Results of a primary screening clinical trial. Cancer 1999;87:354-8.
64. Patten Jr SF, Lee JS, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, et al. The Autopap 300 QS system multicenter clinical trials for use in quality control rescreening of cervical smears. I. A prospective intended use study. Cancer 1997;8:337-42.
65. Patten Jr SF, Lee JS, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, et al. The Autopap 300 QS system multicenter trials for use in quality control rescreening of cervical smears. II. Prospective and archival sensitivity studies. Cancer 1997;81:343-7.
66. Vassilakos P, Carrel S, Petignat P, Boulvain M, Campana A. Use of automated primary screening on liquid-based, thin layer preparations. Acta Cytol 2002;46:291-5.
67. Takahashi M, Kimura M, Akagi A, Naitoh M. AutoCyte SCREEN interactive automated primary cytology screening system: A preliminary evaluation. Acta Cytol 1998;42:185-8.
68. Bishop JW, Kaufman RH, Taylor DA. Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations. Acta Cytol 1999;43:34-8.
69. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results [see comments]. JAMA 1999;281:1605-10.
70. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
71. Vassilakos P, Petignat P, Boulvain M, Campana A. Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer 2002;86:382-8.
72. Corkill M, Knapp D, Martin J, Hutchinson ML. Specimen adequacy of ThinPrep sample preparations in a direct-to-vial study. Acta Cytol 2002;41:39-44.
73. Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CR. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear. Med J Aust 1997;167:466-9.
74. Bolick DR, Hellman DJ. Laboratory Implementation and Efficacy Assessment of the ThinPrep Cervical Cancer Screening System. Acta Cytol 1998;42:209-13.
75. Weintraub J, Wenger D. A large scale investigator-sponsored field study of the test performance of the ThinPrep Papanicolaou test in a low-risk routine outpatient setting. Primary Care Update Obstetrics and Gynecology 1998;5:164.